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Abstract
Understanding the molecular events that regulate osteoblast differentiation is essential for
the development of effective approaches to bone regeneration. In this study, we analysed
the osteoinductive properties of extracellular calcium in bone marrow-derived mesenchymal
stem cell (BM-MSC) differentiation. We cultured BM-MSCs in 3D gelatin scaffolds with Ca2+
and BMP-2 as osteoinductive agents. Early and late osteogenic gene expression and bone
regeneration in a calvarial critical-size defect model demonstrate that extracellular Ca2+
enhances the effects of BMP-2 on Osteocalcin, Runx2 and Osterix expression and pro-
motes bone regeneration in vivo. Moreover, we analysed the molecular mechanisms
involved and observed an antagonistic effect between Ca2+ and BMP-2 on SMAD1/5, ERK
and S6K signalling after 24 hours. More importantly, a cooperative effect between Ca2+ and
BMP-2 on the phosphorylation of SMAD1/5, S6, GSK3 and total levels of β-CATENIN was
observed at a later differentiation time (10 days). Furthermore, Ca2+ alone favoured the
phosphorylation of SMAD1, which correlates with the induction of Bmp2 and Bmp4 gene
expression. These data suggest that Ca2+ and BMP-2 cooperate and promote an autocrine/
paracrine osteogenic feed-forward loop. On the whole, these results demonstrate the use-
fulness of calcium-based bone grafts or the addition of exogenous Ca2+ in bone tissue
engineering.
Introduction
The combination of calcium-containing biomaterials and mesenchymal progenitors is
regarded as a potential bone graft substitute in tissue engineering. In fact, bone is a heteroge-
neous biocomposite tissue that consists of an inorganic phase (essentially hydroxyapatite), an
organic phase (mainly type I collagen) and cells [1] Physiological bone remodelling occurs
when osteoblast precursors attach, differentiate and replace the bone previously resorbed by
osteoclasts. Thus, osteoblast progenitors differentiate after exposure to multiple degradation
products released by osteoclasts. The bone components released presented high extracellular
calcium concentrations, collagen fragments and growth factors.
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Functional type I collagen has a unique triple helical structure that uncoils during degrada-
tion to generate gelatin. This uncoiling exposes its RGD sequences, which promote integrin
binding and cell attachment [2]. Unlike collagen, gelatin does not present antigenicity in phys-
iological conditions [3]. These properties make gelatin an appropriate scaffold for use in 3D
cell cultures [3]
Ca2+ levels differ significantly in different bone niches. Calcium from bone matrix is released
in its ionic form into the remodelling microenvironment [4]. For instance, in the hemivacuole,
studies have reported values in the range of 8–40 mM, in contrast to the non-resorbing surface
of the osteoclast, where values were< 2 mM during resorption [5]. This local increment of
Ca2+ concentration has a strong impact on the chemotaxis, proliferation and differentiation of
osteoblasts [6]. Mechanistically, extracellular Ca2+ activates calcium-sensing receptors (CaSR).
CaSRs are G protein-coupled receptors that are expressed in mesenchymal stem cells and osteo-
blasts [7], although their functional role in bone homeostasis remains unclear. Furthermore,
voltage-gated Ca2+ channels increase intracellular Ca2+ levels in osteoblasts [8]. The maximum
effects of extracellular Ca2+ on osteoprogenitor migration and differentiation are achieved at
concentrations in the range of 2–10 mM [6]. However, although the osteoconductive or osteo-
inductive properties of Ca2+-containing scaffolds have been thoroughly exploited [9], little is
known about their intracellular signal transduction in osteoblasts [10].
Osteogenic growth factors might be secreted by bone resident cells or released from bone
matrix during bone remodelling. These factors that are released after resorption include sev-
eral members of the TGFβ/BMP superfamily of osteogenic signals. TGFβ/BMP signals at the
cell surface are transduced by the Smad family of transcription factors, which directly regulate
gene expression and additional non-canonical pathways such as p38 MAP-kinase and phos-
phoinositide 3-kinase (PI3K)/AKT [11]. BMP target genes include a growing number of
osteoblast-determining transcription factors such as Dlx5, Runx2 and Osterix [12,13]. More
importantly, the efficacy of BMPs in bone regeneration is well known in both animal models
and clinical applications such as bone fracture healing [14], alveolar cleft defects [15], spinal
fusion [16] and craniofacial bone defects [17,18]. As a result, BMP-2 and BMP-7 have been
approved for medical use in specific osteoinductive applications.
Tissue engineered scaffolds for bone regeneration should lead to the attachment, propaga-
tion, and differentiation of the transplanted cells. Thus, there are three main components in
the field of bone tissue engineering: a scaffold that provides structure and substrate for tissue
growth, a source of progenitor cells and stimuli to direct growth and differentiation within
the scaffold [9]. Despite early successes, many challenges are still faced. For instance, beside
improvement of individual components, understanding the interactions between them is key
for success [19]. We combined bone marrow-derived mesenchymal stem cells (BM-MSCs)
and 3D gelatin scaffolds with Ca2+ and BMP-2 as osteoinductive agents. In an attempt to
define the mechanisms of osteoinduction by Ca2+, we first assessed the potential effects of
Ca2+ on osteoblast differentiation and bone formation and its cooperation with BMP-2. More
importantly, we identified the molecular mechanisms involved in this cooperative osteogenic
interaction. We propose that knowledge of these signalling events induced by Ca2+ could bene-
fit the field of bone tissue engineering.
Materials and methods
Isolation and culture of bone marrow-derived mesenchymal stem cells
(BM-MSCs)
BM-MSCs were isolated from the femurs of 6–8 week old BALB/c mice, as previously described
[20,21]. Mice were euthanised and the femurs dissected. Next, the soft tissues were cleaned and
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the femurs kept in complete media (DMEM supplemented with 10% FBS, penicillin/streptomy-
cin, 1 mM pyruvate and 2 mM glutamine). The femur ends were cut using a rongeur and the
bone marrow was flushed and collected. Cell suspension was filtered with a 70 μm cell strainer
(Falcon, USA), transferred to a 100 mm cell culture plate and incubated at 37˚C. The media was
changed after 24 hours and then every eight hours for two to three days to discard non-adherent
cells. After five to seven days, when the adherent cells reached 75%-80% of confluence, the cells
were washed three times with warmed PBS and trypsinised for three minutes at room tempera-
ture. The lifted cells were cultured and expanded for future experiments.
2D gelatin coating and 3D gelatin scaffold preparation
Twelve-well plate surfaces were coated with a thin layer of 0.1% gelatin/PBS solution. Plates
were left for one hour inside a laminar flow hood to dry the treated surfaces and then stored
until use. To prepare 3D scaffolds, a 1 mm3 gelatin sponge (Gelita, B. Braun) was used.
Sponges were cut into 1 mm thick slices for in vitro assays, whereas 2 mm slices were used for
the in vivo experiments. Scaffolds were soaked in complete media and incubated for 12–24
hours at 37˚C. The BM-MSCs (2x 105 cells in 20 μl of media per scaffold) were then seeded
under sterile conditions into the gelatin scaffold, and everything was introduced into a micro-
centrifuge tube and incubated in a vertical position for four to six hours at 37˚C. This seeding
allowed efficient and equal attachment of the cells to the scaffold. To assess the effect of extra-
cellular calcium on the osteoblast differentiation of BM-MSCs, CaSO4 or CaCl2 (Sigma-
Aldrich) was used as source of Ca2+. BM-MSCs seeded on 3D gelatin scaffolds were cultured
in the presence of different CaCl2 or CaSO4 concentrations in the culture media, which ranged
from 3 mM to 10 mM, throughout the whole experimental period. Fresh media (100 μl) was
added to the corresponding condition every three days.
Gene expression analysis by RT-qPCR
RNA isolation was performed using Trisure (Bioline Reagents, UK) in accordance with the
manufacturer’s protocol. The purified RNA was quantified using a spectrophotometer (Nano-
drop). Two micrograms of RNA were retrotranscribed to cDNA using a High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems) in accordance with the manufacturer’s proto-
col. The gene expression of Alpl (Mm00475834.m1), Osteocalcin (Bglap2) (Mm03413826.m1),
Runx2 (Mm03003491.m1), Osterix(Sp7) (Mm00504574.m1), Bmp2 (Mm01340178.m1), Bmp4
(Mm00432087.m1), Fgf21 (Mm00840165.g1) and Axin2 (Mm00443610.m1) was analysed
using Taqman probes (Applied Biosystems) and normalised to Gapdh (Mm9999915.g1)
expression by the 2ΔΔCt method.
Western blot assay
BM-MSCs seeded in 3D gelatin scaffolds were cultured for 24 hours or 10 days. Cells were
lysed with 75 μl of lysis buffer (PBS, 1% Triton X-100, 100 mM PMSF, 1 μg/ml pepstatin, 1 μg/
ml leupeptin, 1 mM of sodium orthovanadate, 10 mM NaF and 10 mM β-glycerophosphate)
for one hour at 4˚C. Thirty micrograms of protein samples were subjected to SDS-PAGE and
immunoblotting. Membranes were incubated with different antibodies: pGSK3α/β Ser9/21
(9331S), pSMAD1/5/8 Ser465/467 (9511S) and pS6 Ser235/236 (2211) and pp38 Thr180/
Tyr182 (9211S) from Cell Signaling Technology, pErk1/2 (M5670) from Sigma, β-catenin
(610154) from BD Transduction Laboratories and α-tubulin (T6199) from Sigma, all diluted
to a ratio of 1:1000. Horseradish peroxidase-conjugated secondary antibodies were used, fol-
lowed by incubation with EZ-ECL reagent (Biological Industries). A chemiluminescent image
of the immunoblots was captured with a Fujifilm LAS 3000 device.
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Calvarial critical-size bone defects and in vivo bone regeneration
Procedures for animal experimentation were approved by the Animal Research Ethics Com-
mittee of the University of Barcelona and Generalitat de Catalunya. All methods in animal
experiments were performed according to the approved institutional guidelines. A surgical
procedure was performed in 10-week old male BALB/c mice. Animals were housed individu-
ally and fed ad libitum. Animals were anesthetised with isoflurane inhalation and an intraperi-
toneal injection of buprenorphine (0.05 mg/kg) was administered to provide intraoperative
analgesia. To expose the parietal bones, a longitudinal midline incision was made and the tis-
sues retracted. A circular critical-size bone defect with an outer diameter of 5 mm was carried
out with a trephine bur on the left parietal. We cultured 4x 105 BM-MSCs per scaffold in accor-
dance with the protocol described above for 3D gelatin scaffold preparation. After cells in the
3D gelatin scaffolds had been exposed to the respective conditions for 48 hours, a 1% final con-
centration solution of low melting agarose at 36˚C was added as a gelling agent. Scaffolds were
implanted to fill the bone defects, depending on the respective experimental group. The
incised tissues were sutured and the animals monitored daily during the recovery phase. Five
weeks after surgery, the animals were euthanised and the calvariae dissected.
Histological analysis
After skull fixation with 4% paraformaldehyde for 48 hours, the calvariae were decalcified with
a Decalcifier II (Leica) for two days. They were then dehydrated, embedded in paraffin and cut
into 6 μm sections to examine bone formation. Slides were stained using hematoxylin/eosin
and Masson’s trichrome technique. Histological sections were evaluated using a light micro-
scope (Nikon Eclipse E800). Quantification of the trichrome images was performed from the
images at 4x magnification using ImageJ software.
Statistical analysis
Data were was obtained from at least three independent experiments and presented as mean ±
SEM. Data was analyzed for normality of the distribution by the Kolmogorov-Smirnov test.
ANOVA (Bonferroni’s test) analysis was performed when more than two groups were com-
pared. Differences were considered significant at p values of less than 0.05:

p< .05, p< .01,
and p< .001.
Results
Extracellular calcium increases osteogenic gene expression in
BM-MSCs cultured in 3D gelatin scaffolds
In order to evaluate the influence of the culture system on the osteoblast differentiation of
BM-MSCs, we compared three different culture models: untreated plastic surface, 2D gelatin-
coated surface and 3D gelatin scaffold. Cells seeded on 3D gelatin scaffolds showed greater
upregulation of all osteogenic markers evaluated (Alpl p< 0.001; Osteocalcin p< 0.001 and
Osterix p< 0.001) than monolayers on plastic surfaces or 2D gelatin coated plates (S1 Fig).
This result suggests that 3D gelatin scaffolds promote higher osteoblast differentiation than
plastic or 2D gelatin-coated surfaces.
We then assessed whether extracellular Ca2+ could have a beneficial effect on osteoblast dif-
ferentiation. We evaluated the effects of different Ca2+ concentrations on BM-MSCs using the
three culture systems described above. Higher expressions of Alpl, Osteocalcin and Osterix
were obtained using Ca2+ concentrations from 3 mM to 10 mM (Fig 1). A concentration of 7.5
mM was optimal for the late osteogenic differentiation markers Osteocalcin and Osterix. Taken
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Fig 1. Extracellular calcium induces expression of osteogenic markers on bone marrow
mesenchymal stem cells. Three different culture models were compared (cells in monolayer in plastic
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together, these results suggest that extracellular Ca2+ concentrations of between 3 mM and 10
mM produce a beneficial effect on the expression of Osteocalcin and Osterix, regardless of the
culture model used. We confirmed the specificity of these effects by comparing CaSO4 and
CaCl2 as calcium ion sources or by chelating Ca
2+ with EDTA. Both CaSO4 and CaCl2 stimu-
lated the expression of osteogenic markers. Moreover, the addition of EDTA completely
blocked the positive effects of CaSO4 and CaCl2 on gene expression (S2 Fig).
Cooperation of calcium and BMP-2 in osteoblast differentiation and bone
regeneration of calvarial critical-size defects in mice
We further evaluated whether Ca2+ would cooperate with osteoinductive cytokines such as
BMPs. BM-MSCs were cultured in a 3D gelatin scaffold and stimulated with 7.5 mM CaSO4
and/or BMP-2 (2 nM). Incubation for 10 days with CaSO4 or BMP-2 alone promoted expres-
sion of all the bone markers analysed (Fig 2). More importantly, although a combination of
Ca2+ and BMP-2 did not present any additive effects on the expression of the early osteogenic
marker Alpl, they produced a significant additive effect on the expression of Osteocalcin,
Runx2 and Osterix (Fig 2). Thus, when added to culture media, Ca2+ exerts a cooperative
action with BMP-2 on late osteogenic marker expression.
To extend our in vitro results on the cooperation between Ca2+ and BMPs to an in vivo con-
text, we analysed bone formation in calvarial critical-size bone defects in mice. Five-millimetre
surface, cells in monolayer in gelatin-coated dishes and cells in 3D gelatin scaffolds). After 10 days, the
mRNA expression of Alpl, Osteocalcin (Bglap2) and Osterix was analysed and normalised to Gapdh levels
(n = 3). Differences were considered significant at p values: * p < 0.05,** p < 0.01, and ***p < 0.001.
https://doi.org/10.1371/journal.pone.0178158.g001
Fig 2. Extracellular calcium increases the effects of BMP-2 on osteogenic marker expression. Primary BM-MSCs were cultured on 3D gelatin
scaffolds with 7.5 mM of CaSO4 and/or 2 nM of BMP-2 for 10 days. The mRNA expression of Alpl, Osteocalcin (Bglap2), Runx2 and Osterix was analysed
and normalised to Gapdh levels (n = 3). Differences were considered significant at p values: * p < 0.05,** p < 0.01, and ***p < 0.001.
https://doi.org/10.1371/journal.pone.0178158.g002
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defects were performed in parietal bones and further implanted with BM-MSCs previously
seeded in 3D gelatin scaffolds and pre-treated for 48 hours with either 7.5 mM CaSO4 or 2 nM
BMP-2 alone or combined. After five weeks, skulls were retrieved and analysed for bone for-
mation in the defect. Masson’s trichrome stains showed dense connective tissue but no major
bone formation in the control group. Higher levels of mineralisation and bone maturation
were found in those implants treated with BMP-2. Similarly, higher bone formation took place
when implants were pre-treated by combination of CaSO4 and BMP-2 (Fig 3). Moreover, a
combination of CaSO4 and BMP-2 led to a more mature bone structure. Both osteoblast and
osteocytes can be observed in these bone regeneration areas (Fig 3).
Signalling pathways involved in the cooperation of calcium and BMP-2
during osteogenesis of BM-MSCs
To determine the mechanisms of cooperation between extracellular calcium and BMP-2 in
BM-MSCs differentiation, we analysed intracellular signalling triggered by both signalling mol-
ecules at early and late differentiation points. Early analysis was performed 24 hours after
CaSO4 and/or BMP-2 stimulation. As expected, BMP-2 promoted phosphorylation of SMAD1/
5 and increased the levels of phosphorylated ERK1/2 (Fig 4). By contrast, p38 and S6-kinase
(S6K) signalling pathways were activated when cells were treated with Ca2+ alone. It is worth
noting that, at this initial differentiation stage, an antagonistic effect on each signalling pathways
was obtained when Ca2+ was added together with BMP-2 (Fig 4).
The same intracellular components were subsequently assessed after treatment with a com-
bination of CaSO4 and/or BMP-2 for 10 days. A significant additive or cooperative effect
between Ca2+ and BMP-2 was observed on the phosphorylation levels of SMAD1/5 (Ser463-
465), S6 (Ser235-236), GSK3β (Ser9) and the total levels of β-CATENIN (Fig 5). Phosphoryla-
tion at Ser9 of GSK3β is mediated by AKT and results in the inhibition of its β-CATENIN
repression action. Thus, these results suggest that extracellular calcium produces a differential
time-dependent effect on BMP-2 and AKT signalling. A signalling network antagonistic to
BMP-2 is activated early on, whereas Ca2+ promotes a cooperative effect on several intracellu-
lar signalling events later on.
Extracellular calcium promotes endogenous secreted BMP-2 and BMP-
4 mRNA expression
After 10 days of differentiation, BM-MSCs stimulated with calcium alone showed activation of
the SMAD1/5 pathway (Fig 5). Since there is no evidence that calcium activates BMP receptors
directly, it could be suggested that the increased availability of BMP receptor ligands was re-
sponsible. We therefore hypothesised that, once these cells are committed to the osteoblast
lineage, Ca2+ induces cells to secrete endogenous factors that reinforce differentiation through
an autocrine/paracrine mechanism. We assayed whether Ca2+ induced BMP-2 or BMP-4
expression. BM-MSCs cultured in 3D gelatin scaffolds were exposed to CaSO4 concentrations
(from 3 mM to 10 mM) for 10 days. An increase, which reached its maximum at 7.5 mM, was
obtained for both Bmp2 and Bmp4 mRNA expression (Fig 6). In addition, we also determined
the mRNA levels of Fgf21 (a tyrosine kinase receptor ligand that inhibits osteoblastogenesis
[22] and Axin2 (a target of the Wnt/β-CATENIN pathway downstream of GSK3). A significant
increase in Axin2 expression was found, in line with Bmp2 and Bmp4 mRNA expression. By
contrast, Fgf21mRNA expression was only slightly elevated, without any dose-response effect
(Fig 6). Taken together, these results demonstrate that BM-MSCs stimulated with Ca2+ secrete
higher levels of multiple critical cytokines that amplify their osteoblastic differentiation
response.
Calcium amplifies BMP signaling and bone formation
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Fig 3. Extracellular calcium increases the effects of BMP-2 on bone regeneration in vivo. Calvarial
critical-size bone defects were generated in mice and implanted with cells cultured in 3D scaffolds pre-treated
Calcium amplifies BMP signaling and bone formation
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Discussion
Different anatomical zones are used to obtain autogenous bone grafts to reconstruct bone
defects. These sources include the iliac crest, cranial bone, mandibular symphysis, rib and tibia
[23]. However, drawbacks include limited availability and morbidity at the donor site. To over-
come these disadvantages, numerous tissue engineering approaches have been developed to
take advantage of physiological osteoinductive signals [24]. Both Ca2+ and BMP-2 are known
to be co-released into the extracellular space by osteoclasts after bone matrix resorption. Our
hypothesis was that extracellular Ca2+ signals interact with BMP and lead to higher osteoblast
differentiation and bone formation from BM-MSCs. Here, early and late osteogenic marker
expression and histological assessment of bone regeneration in a calvarial critical-size defect
model demonstrated that extracellular Ca2+ enhances the effects of BMP-2 on Osteocalcin,
Runx2 and Osterix expression and promotes bone regeneration in vivo. More importantly,
with 7.5 mM of CaSO4 and/or 2 nM of BMP-2 for 48 hours. After five weeks, the implanted constructs were
retrieved and processed for Masson’s trichrome staining. Scale bars are shown for the different magnifications.
Lower panels show the relative quantification of the areas of new bone formation from the 4x magnification
stained by thrichrome in red or blue (n = 3).
https://doi.org/10.1371/journal.pone.0178158.g003
Fig 4. Early effects of extracellular calcium on cell signalling. Cells were cultured in 3D gelatin scaffolds with Ca2+ (7.5 mM) and/or BMP-2
(2nM) for 24 hours and extracts analysed by Western blot. Data was quantified relative to the levels of α-TUBULIN (n = 3). Differences were
considered significant at p values: * p < 0.05,** p < 0.01, and ***p < 0.001.
https://doi.org/10.1371/journal.pone.0178158.g004
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mechanistically, both osteoinductors combined cooperate to increase long-term activation of
SMAD and AKT signalling.
Osteogenic gene expression was significantly higher when extracellular Ca2+ was added,
regardless of the cell culture system used. MG63 osteoblastic cells, both in monolayer culture
and 3D gelatin hydrogels, have been reported to show significant mineralisation when cultured
with 8 mM Ca2+ [25]. Moreover, BM-MSCs treated simultaneously with two different sources
of Ca2+, CaSO4 and CaCl2, with or without EDTA, demonstrated that the osteogenic effect was
specific for Ca2+. This outcome is consistent with the EGTA inhibition of osteocalcin secretion
[26] and BAPTA, an intracellular Ca2+ chelator, in the response of osteoblasts to extracellular
calcium [27].
Osteoinductive factors released from resident cells or after osteoclast bone resorption regu-
late the recruitment and differentiation of osteoblastic progenitor cells. The binding of BMPs
to their cognate receptors triggers canonical Smad and Smad-independent pathways, includ-
ing ERK, p38 and PI3K/AKT signalling [11,28]. Several authors have reported that CaSR acti-
vation by extracellular Ca2+ also activates these same pathways [4,27,29]. We found that both
Fig 5. Late effects of extracellular calcium on cell signalling. Cells were cultured in 3D gelatin scaffolds with Ca2+ (7.5 mM) and/or BMP-2 (2nM) for 10
days. Data was quantified relative to the levels of α-TUBULIN (n = 3). Differences were considered significant at p values: * p < 0.05, ** p < 0.01, and
***p < 0.001.
https://doi.org/10.1371/journal.pone.0178158.g005
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calcium and BMP-2 induce activation of common signalling components, but in a differential
time-dependent response. An early antagonistic effect between Ca2+ and BMP-2 signalling
was demonstrated. This contrasting effect is consistent with previous reports showing a cross-
talk between calcium signalling and BMP pathway in which high intracellular calcium inhibits
BMP signalling [30]. Furthermore, Ca2+/calmodulin dependent kinase II (CAMKII), a pri-
mary transducer of calcium ions, directly interacts with SMADs and antagonises their function
[31]. This reverse effect could be reinforced when we also consider that MAPK signalling
inhibits BMP signals at the level of SMAD1 [32]. Osteoblast differentiation is a multistep cas-
cade of gene expression that initially supports proliferation and survival [33]. The early promi-
nent proliferative and pro-survival role of the MAPK and AKT/S6K network could induce the
enlargement of the osteogenic progenitor pool[4].
However, when late differentiation events were analysed, Ca2+ and BMP-2 were found to
cooperatively stimulate osteoblast differentiation through the strengthening of specific osteo-
genic signalling pathways. Increases in the phosphorylation of SMAD1/5, S6, GSK3β and
expression of β-CATENIN were consistent with the significantly higher expression of Osteocal-
cin, Runx2 and Osterix and the greater bone formation in vivo [34,35]. Cooperative crosstalk
between Ca2+ and BMP-2 in osteoblasts through the induction of the calcium-dependent tran-
scription factor NFATc1 by BMP-2 has also been described recently [36]. NFAT transcription
factors have proved necessary for osteoblast differentiation and bone formation [37]. Mecha-
nistically, NFAT transcription factors activate osteogenesis through their interaction with OSX
and their ability to stimulate Wnt/β-CATENIN signalling [37,38]. Unexpectedly, cell cultures
exposed to Ca2+ alone for 10 days displayed significantly higher SMAD signalling. This obser-
vation correlated with the increase in Bmp2, Bmp4 and Axin2 gene expression. BM-MSCs,
periodontal ligament cells and dental pulp cells exposed to calcium-derived biomaterials have
been reported to induce the upregulation of Bmp2 mRNA expression [8,39,40]. These studies
implicated MAPK activity and AP-1 transcription factors in such effects [8,41]. Thus, our data
support the suggestion that calcium induces an autocrine/paracrine loop by endogenous BMP
upregulation. Furthermore, Axin2 (a target gene of Wnt/β-CATENIN signalling downstream
of GSK3β) was also expressed in long-term cell cultures. Our group recently showed that
PI3K/AKT activity is relevant in bone formation in vivo and leads to the activation of SMAD1/
Fig 6. Extracellular calcium induces Bmp2, Bmp4, Fgf21 and Axin2 mRNA expression. BM-MSCs were cultured on 3D gelatin scaffolds with different
extracellular calcium concentrations for 10 days. The mRNA expression of Bmp2, Bmp4, Fgf21 and Axin2 was analysed and normalised to the levels of
Gapdh (n = 3). Differences were considered significant at p values: * p < 0.05,** p < 0.01, and ***p < 0.001.
https://doi.org/10.1371/journal.pone.0178158.g006
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5 and GSK3β/β-CATENIN signalling [35]. Several reports have demonstrated the synergistic
interaction and the significance between BMP and Wnt during osteoblast differentiation and
bone formation in vitro and in vivo [21,34]. Taken together, our results demonstrate a delayed
calcium signalling effect that likely integrates and reinforces an osteogenic programme from
multiple inputs.
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S1 Fig. 3D gelatin scaffolds positively influence the expression of osteogenic markers.
Three different culture models were compared (cells cultured in monolayer in plastic surface,
cells cultured in monolayer in gelatin-coated dishes and cells cultured in 3D gelatin scaffolds).
Primary BM-MSCs were cultured in each system for 10 days. The mRNA expression of Alpl,
Osteocalcin (Bglap2) and Osterix was analysed and normalised to the levels of Gapdh (n = 3).
(PDF)
S2 Fig. EDTA abrogates the effects of calcium on osteogenic marker expression. BM-MSCs
cultured in 3D gelatin scaffolds were exposed to CaSO4 and CaCl2 as a source of extracellular
calcium (7.5 mM) with or without EDTA (7.5 mM). After 10 days, the mRNA expression of
Osteocalcin (Bglap2), Runx2 and Osterix was analysed and normalised to the levels of Gapdh
(n = 3).
(PDF)
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